Global Cannabis-based Medicines Market Growth (Status and Outlook) 2025-2031

September 2025 | 92 pages | ID: G68EC71E4D9EN
LP Information

Abstracts

According to this study, the global Cannabis-based Medicines market size will reach US$ million by 2031.

Marijuana (medical cannabis) is used to treat nausea, pain, anxiety, MS, insomnia, epilepsy, and other conditions. Tetrahydrocannabinol (THC) and cannabidiol (CBD) are the main chemicals used in medicine. In the medicines market, Epidiolex, the first cannabis-based medication approved by the US Food and Drug Administration.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Cannabis-based Medicines Industry Forecast” looks at past sales and reviews total world Cannabis-based Medicines sales in 2024, providing a comprehensive analysis by region and market sector of projected Cannabis-based Medicines sales for 2025 through 2031. With Cannabis-based Medicines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cannabis-based Medicines industry.

This Insight Report provides a comprehensive analysis of the global Cannabis-based Medicines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cannabis-based Medicines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cannabis-based Medicines market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cannabis-based Medicines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cannabis-based Medicines.

This report presents a comprehensive overview, market shares, and growth opportunities of Cannabis-based Medicines market by product type, application, key players and key regions and countries.

Segmentation by Type:

• CBD (Cannabidiol) Based
• THC (Tetrahydrocannabinol) Based
• Others

Segmentation by Application:

• Oral Solution
• Tablets
• Patches
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• GW Pharmaceuticals plc
• INSYS Therapeutics
• Aequus Pharmaceuticals
• Axim Biotechnologies
• Revive Therapeutics
• MGC Pharmaceuticals
• ECHO Pharmaceuticals

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Cannabis-based Medicines Market Size (2020-2031)
  2.1.2 Cannabis-based Medicines Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Cannabis-based Medicines by Country/Region (2020, 2024 & 2031)
2.2 Cannabis-based Medicines Segment by Type
  2.2.1 CBD (Cannabidiol) Based
  2.2.2 THC (Tetrahydrocannabinol) Based
  2.2.3 Others
2.3 Cannabis-based Medicines Market Size by Type
  2.3.1 Cannabis-based Medicines Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Cannabis-based Medicines Market Size Market Share by Type (2020-2025)
2.4 Cannabis-based Medicines Segment by Application
  2.4.1 Oral Solution
  2.4.2 Tablets
  2.4.3 Patches
  2.4.4 Others
2.5 Cannabis-based Medicines Market Size by Application
  2.5.1 Cannabis-based Medicines Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Cannabis-based Medicines Market Size Market Share by Application (2020-2025)

3 CANNABIS-BASED MEDICINES MARKET SIZE BY PLAYER

3.1 Cannabis-based Medicines Market Size Market Share by Player
  3.1.1 Global Cannabis-based Medicines Revenue by Player (2020-2025)
  3.1.2 Global Cannabis-based Medicines Revenue Market Share by Player (2020-2025)
3.2 Global Cannabis-based Medicines Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 CANNABIS-BASED MEDICINES BY REGION

4.1 Cannabis-based Medicines Market Size by Region (2020-2025)
4.2 Global Cannabis-based Medicines Annual Revenue by Country/Region (2020-2025)
4.3 Americas Cannabis-based Medicines Market Size Growth (2020-2025)
4.4 APAC Cannabis-based Medicines Market Size Growth (2020-2025)
4.5 Europe Cannabis-based Medicines Market Size Growth (2020-2025)
4.6 Middle East & Africa Cannabis-based Medicines Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Cannabis-based Medicines Market Size by Country (2020-2025)
5.2 Americas Cannabis-based Medicines Market Size by Type (2020-2025)
5.3 Americas Cannabis-based Medicines Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Cannabis-based Medicines Market Size by Region (2020-2025)
6.2 APAC Cannabis-based Medicines Market Size by Type (2020-2025)
6.3 APAC Cannabis-based Medicines Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Cannabis-based Medicines Market Size by Country (2020-2025)
7.2 Europe Cannabis-based Medicines Market Size by Type (2020-2025)
7.3 Europe Cannabis-based Medicines Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Cannabis-based Medicines by Region (2020-2025)
8.2 Middle East & Africa Cannabis-based Medicines Market Size by Type (2020-2025)
8.3 Middle East & Africa Cannabis-based Medicines Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL CANNABIS-BASED MEDICINES MARKET FORECAST

10.1 Global Cannabis-based Medicines Forecast by Region (2026-2031)
  10.1.1 Global Cannabis-based Medicines Forecast by Region (2026-2031)
  10.1.2 Americas Cannabis-based Medicines Forecast
  10.1.3 APAC Cannabis-based Medicines Forecast
  10.1.4 Europe Cannabis-based Medicines Forecast
  10.1.5 Middle East & Africa Cannabis-based Medicines Forecast
10.2 Americas Cannabis-based Medicines Forecast by Country (2026-2031)
  10.2.1 United States Market Cannabis-based Medicines Forecast
  10.2.2 Canada Market Cannabis-based Medicines Forecast
  10.2.3 Mexico Market Cannabis-based Medicines Forecast
  10.2.4 Brazil Market Cannabis-based Medicines Forecast
10.3 APAC Cannabis-based Medicines Forecast by Region (2026-2031)
  10.3.1 China Cannabis-based Medicines Market Forecast
  10.3.2 Japan Market Cannabis-based Medicines Forecast
  10.3.3 Korea Market Cannabis-based Medicines Forecast
  10.3.4 Southeast Asia Market Cannabis-based Medicines Forecast
  10.3.5 India Market Cannabis-based Medicines Forecast
  10.3.6 Australia Market Cannabis-based Medicines Forecast
10.4 Europe Cannabis-based Medicines Forecast by Country (2026-2031)
  10.4.1 Germany Market Cannabis-based Medicines Forecast
  10.4.2 France Market Cannabis-based Medicines Forecast
  10.4.3 UK Market Cannabis-based Medicines Forecast
  10.4.4 Italy Market Cannabis-based Medicines Forecast
  10.4.5 Russia Market Cannabis-based Medicines Forecast
10.5 Middle East & Africa Cannabis-based Medicines Forecast by Region (2026-2031)
  10.5.1 Egypt Market Cannabis-based Medicines Forecast
  10.5.2 South Africa Market Cannabis-based Medicines Forecast
  10.5.3 Israel Market Cannabis-based Medicines Forecast
  10.5.4 Turkey Market Cannabis-based Medicines Forecast
10.6 Global Cannabis-based Medicines Forecast by Type (2026-2031)
10.7 Global Cannabis-based Medicines Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Cannabis-based Medicines Forecast

11 KEY PLAYERS ANALYSIS

11.1 GW Pharmaceuticals plc
  11.1.1 GW Pharmaceuticals plc Company Information
  11.1.2 GW Pharmaceuticals plc Cannabis-based Medicines Product Offered
  11.1.3 GW Pharmaceuticals plc Cannabis-based Medicines Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 GW Pharmaceuticals plc Main Business Overview
  11.1.5 GW Pharmaceuticals plc Latest Developments
11.2 INSYS Therapeutics
  11.2.1 INSYS Therapeutics Company Information
  11.2.2 INSYS Therapeutics Cannabis-based Medicines Product Offered
  11.2.3 INSYS Therapeutics Cannabis-based Medicines Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 INSYS Therapeutics Main Business Overview
  11.2.5 INSYS Therapeutics Latest Developments
11.3 Aequus Pharmaceuticals
  11.3.1 Aequus Pharmaceuticals Company Information
  11.3.2 Aequus Pharmaceuticals Cannabis-based Medicines Product Offered
  11.3.3 Aequus Pharmaceuticals Cannabis-based Medicines Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Aequus Pharmaceuticals Main Business Overview
  11.3.5 Aequus Pharmaceuticals Latest Developments
11.4 Axim Biotechnologies
  11.4.1 Axim Biotechnologies Company Information
  11.4.2 Axim Biotechnologies Cannabis-based Medicines Product Offered
  11.4.3 Axim Biotechnologies Cannabis-based Medicines Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Axim Biotechnologies Main Business Overview
  11.4.5 Axim Biotechnologies Latest Developments
11.5 Revive Therapeutics
  11.5.1 Revive Therapeutics Company Information
  11.5.2 Revive Therapeutics Cannabis-based Medicines Product Offered
  11.5.3 Revive Therapeutics Cannabis-based Medicines Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Revive Therapeutics Main Business Overview
  11.5.5 Revive Therapeutics Latest Developments
11.6 MGC Pharmaceuticals
  11.6.1 MGC Pharmaceuticals Company Information
  11.6.2 MGC Pharmaceuticals Cannabis-based Medicines Product Offered
  11.6.3 MGC Pharmaceuticals Cannabis-based Medicines Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 MGC Pharmaceuticals Main Business Overview
  11.6.5 MGC Pharmaceuticals Latest Developments
11.7 ECHO Pharmaceuticals
  11.7.1 ECHO Pharmaceuticals Company Information
  11.7.2 ECHO Pharmaceuticals Cannabis-based Medicines Product Offered
  11.7.3 ECHO Pharmaceuticals Cannabis-based Medicines Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 ECHO Pharmaceuticals Main Business Overview
  11.7.5 ECHO Pharmaceuticals Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Cannabis-based Medicines Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Cannabis-based Medicines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of CBD (Cannabidiol) Based
Table 4. Major Players of THC (Tetrahydrocannabinol) Based
Table 5. Major Players of Others
Table 6. Cannabis-based Medicines Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Cannabis-based Medicines Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Cannabis-based Medicines Market Size Market Share by Type (2020-2025)
Table 9. Cannabis-based Medicines Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Cannabis-based Medicines Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Cannabis-based Medicines Market Size Market Share by Application (2020-2025)
Table 12. Global Cannabis-based Medicines Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Cannabis-based Medicines Revenue Market Share by Player (2020-2025)
Table 14. Cannabis-based Medicines Key Players Head office and Products Offered
Table 15. Cannabis-based Medicines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Cannabis-based Medicines Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Cannabis-based Medicines Market Size Market Share by Region (2020-2025)
Table 20. Global Cannabis-based Medicines Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Cannabis-based Medicines Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Cannabis-based Medicines Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Cannabis-based Medicines Market Size Market Share by Country (2020-2025)
Table 24. Americas Cannabis-based Medicines Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Cannabis-based Medicines Market Size Market Share by Type (2020-2025)
Table 26. Americas Cannabis-based Medicines Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Cannabis-based Medicines Market Size Market Share by Application (2020-2025)
Table 28. APAC Cannabis-based Medicines Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Cannabis-based Medicines Market Size Market Share by Region (2020-2025)
Table 30. APAC Cannabis-based Medicines Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Cannabis-based Medicines Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Cannabis-based Medicines Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Cannabis-based Medicines Market Size Market Share by Country (2020-2025)
Table 34. Europe Cannabis-based Medicines Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Cannabis-based Medicines Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Cannabis-based Medicines Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Cannabis-based Medicines Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Cannabis-based Medicines Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Cannabis-based Medicines
Table 40. Key Market Challenges & Risks of Cannabis-based Medicines
Table 41. Key Industry Trends of Cannabis-based Medicines
Table 42. Global Cannabis-based Medicines Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Cannabis-based Medicines Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Cannabis-based Medicines Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Cannabis-based Medicines Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. GW Pharmaceuticals plc Details, Company Type, Cannabis-based Medicines Area Served and Its Competitors
Table 47. GW Pharmaceuticals plc Cannabis-based Medicines Product Offered
Table 48. GW Pharmaceuticals plc Cannabis-based Medicines Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. GW Pharmaceuticals plc Main Business
Table 50. GW Pharmaceuticals plc Latest Developments
Table 51. INSYS Therapeutics Details, Company Type, Cannabis-based Medicines Area Served and Its Competitors
Table 52. INSYS Therapeutics Cannabis-based Medicines Product Offered
Table 53. INSYS Therapeutics Cannabis-based Medicines Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. INSYS Therapeutics Main Business
Table 55. INSYS Therapeutics Latest Developments
Table 56. Aequus Pharmaceuticals Details, Company Type, Cannabis-based Medicines Area Served and Its Competitors
Table 57. Aequus Pharmaceuticals Cannabis-based Medicines Product Offered
Table 58. Aequus Pharmaceuticals Cannabis-based Medicines Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Aequus Pharmaceuticals Main Business
Table 60. Aequus Pharmaceuticals Latest Developments
Table 61. Axim Biotechnologies Details, Company Type, Cannabis-based Medicines Area Served and Its Competitors
Table 62. Axim Biotechnologies Cannabis-based Medicines Product Offered
Table 63. Axim Biotechnologies Cannabis-based Medicines Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Axim Biotechnologies Main Business
Table 65. Axim Biotechnologies Latest Developments
Table 66. Revive Therapeutics Details, Company Type, Cannabis-based Medicines Area Served and Its Competitors
Table 67. Revive Therapeutics Cannabis-based Medicines Product Offered
Table 68. Revive Therapeutics Cannabis-based Medicines Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Revive Therapeutics Main Business
Table 70. Revive Therapeutics Latest Developments
Table 71. MGC Pharmaceuticals Details, Company Type, Cannabis-based Medicines Area Served and Its Competitors
Table 72. MGC Pharmaceuticals Cannabis-based Medicines Product Offered
Table 73. MGC Pharmaceuticals Cannabis-based Medicines Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. MGC Pharmaceuticals Main Business
Table 75. MGC Pharmaceuticals Latest Developments
Table 76. ECHO Pharmaceuticals Details, Company Type, Cannabis-based Medicines Area Served and Its Competitors
Table 77. ECHO Pharmaceuticals Cannabis-based Medicines Product Offered
Table 78. ECHO Pharmaceuticals Cannabis-based Medicines Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. ECHO Pharmaceuticals Main Business
Table 80. ECHO Pharmaceuticals Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Cannabis-based Medicines Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cannabis-based Medicines Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Cannabis-based Medicines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Cannabis-based Medicines Sales Market Share by Country/Region (2024)
Figure 8. Cannabis-based Medicines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Cannabis-based Medicines Market Size Market Share by Type in 2024
Figure 10. Cannabis-based Medicines in Oral Solution
Figure 11. Global Cannabis-based Medicines Market: Oral Solution (2020-2025) & ($ millions)
Figure 12. Cannabis-based Medicines inTablets
Figure 13. Global Cannabis-based Medicines Market:Tablets (2020-2025) & ($ millions)
Figure 14. Cannabis-based Medicines in Patches
Figure 15. Global Cannabis-based Medicines Market: Patches (2020-2025) & ($ millions)
Figure 16. Cannabis-based Medicines in Others
Figure 17. Global Cannabis-based Medicines Market: Others (2020-2025) & ($ millions)
Figure 18. Global Cannabis-based Medicines Market Size Market Share by Application in 2024
Figure 19. Global Cannabis-based Medicines Revenue Market Share by Player in 2024
Figure 20. Global Cannabis-based Medicines Market Size Market Share by Region (2020-2025)
Figure 21. Americas Cannabis-based Medicines Market Size 2020-2025 ($ millions)
Figure 22. APAC Cannabis-based Medicines Market Size 2020-2025 ($ millions)
Figure 23. Europe Cannabis-based Medicines Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Cannabis-based Medicines Market Size 2020-2025 ($ millions)
Figure 25. Americas Cannabis-based Medicines Value Market Share by Country in 2024
Figure 26. United States Cannabis-based Medicines Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Cannabis-based Medicines Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Cannabis-based Medicines Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Cannabis-based Medicines Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Cannabis-based Medicines Market Size Market Share by Region in 2024
Figure 31. APAC Cannabis-based Medicines Market Size Market Share by Type (2020-2025)
Figure 32. APAC Cannabis-based Medicines Market Size Market Share by Application (2020-2025)
Figure 33. China Cannabis-based Medicines Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Cannabis-based Medicines Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Cannabis-based Medicines Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Cannabis-based Medicines Market Size Growth 2020-2025 ($ millions)
Figure 37. India Cannabis-based Medicines Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Cannabis-based Medicines Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Cannabis-based Medicines Market Size Market Share by Country in 2024
Figure 40. Europe Cannabis-based Medicines Market Size Market Share by Type (2020-2025)
Figure 41. Europe Cannabis-based Medicines Market Size Market Share by Application (2020-2025)
Figure 42. Germany Cannabis-based Medicines Market Size Growth 2020-2025 ($ millions)
Figure 43. France Cannabis-based Medicines Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Cannabis-based Medicines Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Cannabis-based Medicines Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Cannabis-based Medicines Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Cannabis-based Medicines Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Cannabis-based Medicines Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Cannabis-based Medicines Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Cannabis-based Medicines Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Cannabis-based Medicines Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Cannabis-based Medicines Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Cannabis-based Medicines Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Cannabis-based Medicines Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Cannabis-based Medicines Market Size 2026-2031 ($ millions)
Figure 56. APAC Cannabis-based Medicines Market Size 2026-2031 ($ millions)
Figure 57. Europe Cannabis-based Medicines Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Cannabis-based Medicines Market Size 2026-2031 ($ millions)
Figure 59. United States Cannabis-based Medicines Market Size 2026-2031 ($ millions)
Figure 60. Canada Cannabis-based Medicines Market Size 2026-2031 ($ millions)
Figure 61. Mexico Cannabis-based Medicines Market Size 2026-2031 ($ millions)
Figure 62. Brazil Cannabis-based Medicines Market Size 2026-2031 ($ millions)
Figure 63. China Cannabis-based Medicines Market Size 2026-2031 ($ millions)
Figure 64. Japan Cannabis-based Medicines Market Size 2026-2031 ($ millions)
Figure 65. Korea Cannabis-based Medicines Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Cannabis-based Medicines Market Size 2026-2031 ($ millions)
Figure 67. India Cannabis-based Medicines Market Size 2026-2031 ($ millions)
Figure 68. Australia Cannabis-based Medicines Market Size 2026-2031 ($ millions)
Figure 69. Germany Cannabis-based Medicines Market Size 2026-2031 ($ millions)
Figure 70. France Cannabis-based Medicines Market Size 2026-2031 ($ millions)
Figure 71. UK Cannabis-based Medicines Market Size 2026-2031 ($ millions)
Figure 72. Italy Cannabis-based Medicines Market Size 2026-2031 ($ millions)
Figure 73. Russia Cannabis-based Medicines Market Size 2026-2031 ($ millions)
Figure 74. Egypt Cannabis-based Medicines Market Size 2026-2031 ($ millions)
Figure 75. South Africa Cannabis-based Medicines Market Size 2026-2031 ($ millions)
Figure 76. Israel Cannabis-based Medicines Market Size 2026-2031 ($ millions)
Figure 77. Turkey Cannabis-based Medicines Market Size 2026-2031 ($ millions)
Figure 78. Global Cannabis-based Medicines Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Cannabis-based Medicines Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Cannabis-based Medicines Market Size 2026-2031 ($ millions)